Adverum Biotechnologies, Inc. (ADVM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Adverum Biotechnologies, Inc., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.71x | -3.58x | -2.18x | -11.89x | -86.01x | -131.83x |
| P/B Ratio | 1.31x | 6.49x | 1.85x | 5.48x | 23.27x | 48.59x |
| P/S Ratio | 92.38x | 121.27x | 0.00x | 230.82x | 0.00x | 34005.66x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 0.0% | 100.0% | 0.0% | 0.0% |
| Operating Margin | -13915.9% | -3581.7% | 0.0% | -1948.3% | 0.0% | -27418.0% |
| Net Margin | -13092.7% | -3392.1% | 0.0% | -1940.5% | 0.0% | -25794.4% |
| EBITDA Margin | -13550.6% | -3424.9% | 0.0% | -1886.4% | 0.0% | -26788.8% |
| Liquidity | ||||||
| Current Ratio | 5.73x | 5.14x | 5.91x | 14.88x | 20.82x | 9.06x |
| Quick Ratio | 5.73x | 5.14x | 5.91x | 14.88x | 20.82x | 9.06x |
| Leverage | ||||||
| Debt/Equity | 1.30x | 1.10x | 0.59x | 0.33x | 0.07x | 0.19x |
YoY = year-over-year change. Source: FMP..